Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Biorxiv : the Preprint Server for Biology|August 31, 2021
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strainsBaoling Ying, Bradley Whitener, Laura A VanBlargan, et al.
Vaccine|November 24, 2021
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in miceKai Wu, Angela Choi, Matthew Koch, et al.
Biorxiv : the Preprint Server for Biology|October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variantSuzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in miceKai Wu, Angela Choi, Matthew Koch, et al.
Cell Reports. Medicine|November 2, 2023
An mRNA-based platform for the delivery of pathogen-specific IgA into mucosal secretionsCailin E Deal, Angelene F Richards, Tracy Yeung, et al.
NPJ Vaccines|June 10, 2024
Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in miceM Allison Wolf, Joanne M O'Hara, Graham J Bitzer, et al.
Biorxiv : the Preprint Server for Biology|October 14, 2022
Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domainsGuillaume B E Stewart-Jones, Sayda M Elbashir, Kai Wu, et al.
Nature Medicine|October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in miceSuzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
Science Translational Medicine|September 13, 2023
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2Guillaume B E Stewart-Jones, Sayda M Elbashir, Kai Wu, et al.
Pageof 12